http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2271841-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52f344c74b8020941b2b5efa8a1c849c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 1974-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1975-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2271841-A1 |
| titleOfInvention | Vincamine and vitamin E compsns - having synergistic activity, for treatment tt of cardiac and circulatory disorders |
| abstract | The title compsns. contain a combination of a cellular oxygen conserving factor, esp. vitamin E, and a cellular oxygenator, esp. vincamine. The oxidoreductive properties of vitamin E are potentiated by the vincamine. The vitamin E is pref. alpha-tocophenol, and prefd. compsns. contain 1-10 pts. vincamine and 10-50 pts. alpha-tocopherol, esp. 8-10 mg vincamine and 100 mg alpha-tocopherol acetate. The compsn. also pref. contain a venous wall and capillary protection agent, esp. a vitamin P factor, and pref. trihydroxyethylrutoside or Folescutol. |
| priorityDate | 1974-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.